skip to main content

Tricuspid Regurgitation — EECC MCQ

Instant feedback + full explanation. One question, done properly.

HardValvular Heart DiseaseTricuspid RegurgitationEECC

A 70-year-old woman with severe symptomatic tricuspid regurgitation (secondary to AF-related annular dilatation) has undergone optimisation of medical therapy. She has no left-sided valve disease. Her RV function is moderately impaired. The Heart Team considers her surgical risk to be high. What transcatheter option may be considered?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Transcatheter tricuspid valve repair (TEER) or replacement at an experienced centre

Explanation lettering: B = shown as A · D = shown as B · E = shown as C · A = shown as D · C = shown as E

The 2025 ESC/EACTS VHD Guidelines acknowledge growing evidence for transcatheter tricuspid interventions including TEER (e.g. TriClip) and TTVR in high-surgical-risk patients, at experienced centres. TRILUMINATE Pivotal supports TEER. Balloon valvuloplasty (D) is not applicable for TR. Option C is incorrect as transcatheter options exist.

Reference: ESC/EACTS (2025): Guidelines for the Management of Valvular Heart Disease